Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres

Acta Pharmacologica Sinica

Volumn 23, Issue 11, 2002, Pages 1051-1056

  Pan, Yan ^a   Zheng, Jun Min ^a   Zhao, Hui Ying ^a   Li, Ying Jian ^a   Xu, Hui ^a   Wei, Gang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug effects; Insulin; Microspheres; Oral administration; Particle size

Indexed keywords

INSULIN; MICROSPHERE; POLYSACCHARIDE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; GLUCOSE HOMEOSTASIS; MALE; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHITIN; CHITOSAN; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; HYPOGLYCEMIC AGENTS; INSULIN; MICROSPHERES; PARTICLE SIZE; RATS; RATS, WISTAR;

EID: 0036842367     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 2001; 50: S91-101.
2. Zhang Y, Jiang XG, Yao J. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins. Acta Pharmacol Sin 2001; 22: 1051-6.
3. Luessen HL, de Leeuw BJ, Langemeyer MW, de Boer AB, Verhoef JC, Junginger HE. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 1996; 13: 1668-72.
4. Rog K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunological protection in a murine model of peanut allergy. Nat Med 1999; 5: 389-91.
5. Wats PJ, Barrow L, Steed KP, Wilson CG, Spiller RC, Melia CD, et al. The transit rate of different-sized of model dosage forms through the human colon and the effect of a lactulose-induced catharsis. Int J Pharm 1992; 87: 215-21.
6. Kraehembuhl J-P, Neutra MR. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 1992; 72: 853-79.
7. Jani PU, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanopheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989; 41: 809-21.
8. Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 1996; 14: 1677-85.
9. Wang J, Zhang Q. Uptake of cyclosporine A loaded colloidal drug carriers by mouse peritoneal macrophages in vitro. Acta Pharmacol Sin 2001; 22: 57-61.
10. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery system for macromolecules. Adv Drug Deliv Rev 2001; 47: 83-97.
11. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/thylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 1997; 14: 1431-6.
12. Fernanedz-Urrusuno R, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alouso MJ. Enhancement of nasal absorption of insulin Using chitosan nanoparticles. Pharm Res 1999; 16: 1576-81.
13. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effects of particle size. Pharm Res 1996; 13: 1838-45.
14. He GA, Hou HM, Liu XJ. Naltrexone microspheres: In vitro release and effect on morphine analgesia in mice. Acta Pharmacol Sin 2001; 22: 530-3.
15. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182: 21-32.
16. Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesive of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 2001; 18: 788-93.